Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Twin Brook Capital Partners is a leading direct lending firm that provides tailored financing solutions to middle-market companies, primarily those backed by private equity sponsors. As the middle-market direct lending platform of TPG Angelo Gordon, the firm specializes in senior debt, including revolvers, first lien term loans, and unitranche structures. Twin Brook maintains a dedicated healthcare lending team that focuses on sub-sectors such as healthcare services, medical products, and pharmaceutical services. The firm is particularly known for its 'buy-and-build' support, providing the capital necessary for portfolio companies to execute strategic add-on acquisitions. Since its founding in 2014, Twin Brook has established itself as a reliable partner in the leveraged finance market, having committed billions of dollars across hundreds of transactions. Headquartered in Chicago, the firm leverages deep industry expertise to support the growth and stability of its borrowers throughout their investment lifecycles.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Twin Brook Capital Partners.